Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_assertion type Assertion NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_head.
- NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_assertion description "[Genetic characterization of these ALK-positive tumors indicated that full-length ALK expression in two serous carcinoma patients is consistent with ALK gene copy number gain, whereas a stromal sarcoma patient carries a novel transmembrane ALK fusion gene: FN1-ALK.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_provenance.
- NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_assertion evidence source_evidence_literature NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_provenance.
- NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_assertion SIO_000772 22570254 NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_provenance.
- NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_assertion wasDerivedFrom befree-20140225 NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_provenance.
- NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_assertion wasGeneratedBy ECO_0000203 NP243539.RAueMIBB0YIbLaAgRFVfp_kt4JTzKSVz-0-ARlOvtVneI130_provenance.